Publications by authors named "Nicholas Jessop"

Claim this Profile
I
Integrated Radiology, Pathology, and Pharmacy Program to Accelerate Access to Osimertinib.
Ibiayi Dagogo-Jack, Amanda Manoogian, Nicholas Jessop, N Zeke Georgantas, Florian J Fintelmann

JCO Oncol Pract· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network.
Dora Dias-Santagata, Rebecca S Heist, Adam Z Bard, Annacarolina F L da Silva, Ibiayi Dagogo-Jack, Nicholas Jessop

Oncologist· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic Characteristics of BRG1-Deficient NSCLC.
Ibiayi Dagogo-Jack, Alexa B Schrock, Marina Kem, Nicholas Jessop, Jessica Lee

J Thorac Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma.
Tejus A Bale, Justin T Jordan, Otto Rapalino, Nisha Ramamurthy, Nicholas Jessop

Neuro Oncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-mutant Lung Cancer.
Ibiayi Dagogo-Jack, Pablo Martinez, Beow Y Yeap, Chiara Ambrogio, Lorin A Ferris, Nicholas A Jessop

Clin Cancer Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding the spectrum of pediatric NTRK-rearranged fibroblastic tumors to the central nervous system: A case report with RBPMS-NTRK3 fusion.
Matthew Torre, Nicholas Jessop, Jason L Hornick, Sanda Alexandrescu

Neuropathology· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity and Coexistence of T790M and T790 Wild-Type Resistant Subclones Drive Mixed Response to Third-Generation Epidermal Growth Factor Receptor Inhibitors in Lung Cancer.
Zofia Piotrowska, Mehlika Hazar-Rethinam, Coleen Rizzo, Brandon Nadres, Emily E Van Seventer, Nicholas A Jessop

JCO Precis Oncol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer.
Jessica J Lin, Viola W Zhu, Satoshi Yoda, Beow Y Yeap, Alexa B Schrock, Nicholas A Jessop

J Clin Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in Colorectal Cancer.
Mehlika Hazar-Rethinam, Marianna Kleyman, G Celine Han, David Liu, Leanne G Ahronian, Nicholas A Jessop

Cancer Discov· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining electrostatic powder with an insecticide: effect on stored-product beetles and on the commodity.
Christos G Athanassiou, Thomas N Vassilakos, Anna C Dutton, Nicholas Jessop, David Sherwood

Pest Manag Sci· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer.
Mariangela Russo, Giulia Siravegna, Lawrence S Blaszkowsky, Giorgio Corti, Giovanni Crisafulli, Nicholas A Jessop

Cancer Discov· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Heterogeneity and Receptor Coamplification Drive Resistance to Targeted Therapy in MET-Amplified Esophagogastric Cancer.
Eunice L Kwak, Leanne G Ahronian, Giulia Siravegna, Benedetta Mussolin, Darrell R Borger, Nicholas A Jessop

Cancer Discov· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers.
Ryohei Katayama, Alice T Shaw, Tahsin M Khan, Mari Mino-Kenudson, Benjamin J Solomon, Nicholas A Jessop

Sci Transl Med· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis